▶ 調査レポート

世界の経頭蓋磁気刺激装置市場(~2027):種類別、年齢層別、用途別、地域別

• 英文タイトル:Transcranial Magnetic Stimulation System Market Research Report by Type, Age Group, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の経頭蓋磁気刺激装置市場(~2027):種類別、年齢層別、用途別、地域別 / Transcranial Magnetic Stimulation System Market Research Report by Type, Age Group, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2301C064資料のイメージです。• レポートコード:MRC2301C064
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、248ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査レポートは、2021年に1,294.33百万ドルであった世界の経頭蓋磁気刺激装置市場規模が、2022年に1,425.84百万ドルになり、2027年まで年平均10.41%で成長して2,345.39百万ドルに達すると予測しています。本レポートでは、経頭蓋磁気刺激装置の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別(深部経頭蓋磁気刺激装置(dTMS)、反復経頭蓋磁気刺激装置(rTMS))分析、年齢層別(大人、子供)分析、用途別(アルツハイマー病、うつ病、てんかん、パーキンソン病)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの項目を掲載しています。本書には、Aetna Inc.、Beckman Coulter Inc.、BrainsWay Ltd.、Bumrungrad Hospital Public Company Limited、eNeura Inc.、Johari Digital、MAG & More GmbH、Magstim, Inc.、MagVenture, Inc.、Neuronetics, Inc.、Neuroprex Inc.、Neurosoft、Nexstim Oyj、Salience TMS Neuro Solutionsなどの企業情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の経頭蓋磁気刺激装置市場規模:種類別
- 深部経頭蓋磁気刺激装置(dTMS)の市場規模
- 反復経頭蓋磁気刺激装置(rTMS)の市場規模
・世界の経頭蓋磁気刺激装置市場規模:年齢層別
- 大人における市場規模
- 子供における市場規模
・世界の経頭蓋磁気刺激装置市場規模:用途別
- アルツハイマー病における市場規模
- うつ病における市場規模
- てんかんにおける市場規模
- パーキンソン病における市場規模
・世界の経頭蓋磁気刺激装置市場規模:地域別
- 南北アメリカの経頭蓋磁気刺激装置市場規模
アメリカの経頭蓋磁気刺激装置市場規模
カナダの経頭蓋磁気刺激装置市場規模
ブラジルの経頭蓋磁気刺激装置市場規模
...
- アジア太平洋の経頭蓋磁気刺激装置市場規模
日本の経頭蓋磁気刺激装置市場規模
中国の経頭蓋磁気刺激装置市場規模
インドの経頭蓋磁気刺激装置市場規模
韓国の経頭蓋磁気刺激装置市場規模
台湾の経頭蓋磁気刺激装置市場規模
...
-ヨーロッパ/中東/アフリカの経頭蓋磁気刺激装置市場規模
イギリスの経頭蓋磁気刺激装置市場規模
ドイツの経頭蓋磁気刺激装置市場規模
フランスの経頭蓋磁気刺激装置市場規模
ロシアの経頭蓋磁気刺激装置市場規模
...
-その他地域の経頭蓋磁気刺激装置市場規模
・競争状況
・企業情報

The Global Transcranial Magnetic Stimulation System Market size was estimated at USD 1,294.33 million in 2021 and expected to reach USD 1,425.84 million in 2022, and is projected to grow at a CAGR 10.41% to reach USD 2,345.39 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Transcranial Magnetic Stimulation System to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Deep Transcranial Magnetic Stimulator (dTMS) and Repetitive Transcranial Magnetic Stimulator (rTMS).

Based on Age Group, the market was studied across Adults and Children.

Based on Application, the market was studied across Alzheimer’s Disease, Depression, Epilepsy, and Parkinson’s Disease.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Transcranial Magnetic Stimulation System market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transcranial Magnetic Stimulation System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Transcranial Magnetic Stimulation System Market, including Aetna Inc., Beckman Coulter Inc., BrainsWay Ltd., Bumrungrad Hospital Public Company Limited, eNeura Inc., Johari Digital, MAG & More GmbH, Magstim, Inc., MagVenture, Inc., Neuronetics, Inc., Neuroprex Inc., Neurosoft, Nexstim Oyj, Salience TMS Neuro Solutions, and Storz Medical AG.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Transcranial Magnetic Stimulation System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transcranial Magnetic Stimulation System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transcranial Magnetic Stimulation System Market?
4. What is the competitive strategic window for opportunities in the Global Transcranial Magnetic Stimulation System Market?
5. What are the technology trends and regulatory frameworks in the Global Transcranial Magnetic Stimulation System Market?
6. What is the market share of the leading vendors in the Global Transcranial Magnetic Stimulation System Market?
7. What modes and strategic moves are considered suitable for entering the Global Transcranial Magnetic Stimulation System Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of neurological disorders worldwide
5.1.1.2. Growing consumer awareness toward treatment and prevention of depression issues
5.1.1.3. Rapid adoption of non-invasive and pulse-administered treatments
5.1.2. Restraints
5.1.2.1. High costs of treatment
5.1.3. Opportunities
5.1.3.1. Governmental approvals for improving applicability of transcranial magnetic stimulation systems
5.1.3.2. Ongoing research and development activities for technological advancements
5.1.4. Challenges
5.1.4.1. Unavailability of reimbursement policies with potential side affects of treatment
5.2. Cumulative Impact of COVID-19

6. Transcranial Magnetic Stimulation System Market, by Type
6.1. Introduction
6.2. Deep Transcranial Magnetic Stimulator (dTMS)
6.3. Repetitive Transcranial Magnetic Stimulator (rTMS)

7. Transcranial Magnetic Stimulation System Market, by Age Group
7.1. Introduction
7.2. Adults
7.3. Children

8. Transcranial Magnetic Stimulation System Market, by Application
8.1. Introduction
8.2. Alzheimer’s Disease
8.3. Depression
8.4. Epilepsy
8.5. Parkinson’s Disease

9. Americas Transcranial Magnetic Stimulation System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Transcranial Magnetic Stimulation System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Transcranial Magnetic Stimulation System Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Aetna Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Beckman Coulter Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. BrainsWay Ltd.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bumrungrad Hospital Public Company Limited
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. eNeura Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Johari Digital
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. MAG & More GmbH
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Magstim, Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. MagVenture, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Neuronetics, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Neuroprex Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Neurosoft
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Nexstim Oyj
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Salience TMS Neuro Solutions
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Storz Medical AG
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing